Vesicle mediated transport, vesicule-associated membrane
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 8 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pescher et al. (upgregulation) | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Lahav et al. - mRNA
- Protein
|
Related structures:
AlphaFold database: A4HZC6
Term | Name | Level | Count |
---|---|---|---|
GO:0006810 | transport | 3 | 12 |
GO:0016192 | vesicle-mediated transport | 4 | 12 |
GO:0051179 | localization | 1 | 12 |
GO:0051234 | establishment of localization | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 97 | 101 | PF00656 | 0.514 |
CLV_NRD_NRD_1 | 98 | 100 | PF00675 | 0.312 |
CLV_PCSK_KEX2_1 | 98 | 100 | PF00082 | 0.312 |
CLV_PCSK_SKI1_1 | 113 | 117 | PF00082 | 0.294 |
CLV_PCSK_SKI1_1 | 136 | 140 | PF00082 | 0.289 |
CLV_PCSK_SKI1_1 | 219 | 223 | PF00082 | 0.352 |
CLV_PCSK_SKI1_1 | 23 | 27 | PF00082 | 0.261 |
CLV_PCSK_SKI1_1 | 245 | 249 | PF00082 | 0.602 |
DOC_MAPK_gen_1 | 154 | 162 | PF00069 | 0.461 |
DOC_MAPK_gen_1 | 68 | 76 | PF00069 | 0.536 |
DOC_MAPK_MEF2A_6 | 154 | 162 | PF00069 | 0.485 |
DOC_PP4_FxxP_1 | 116 | 119 | PF00568 | 0.590 |
DOC_PP4_FxxP_1 | 131 | 134 | PF00568 | 0.425 |
DOC_PP4_FxxP_1 | 37 | 40 | PF00568 | 0.530 |
DOC_USP7_MATH_1 | 147 | 151 | PF00917 | 0.641 |
DOC_WW_Pin1_4 | 26 | 31 | PF00397 | 0.582 |
LIG_14-3-3_CanoR_1 | 50 | 54 | PF00244 | 0.519 |
LIG_14-3-3_CanoR_1 | 57 | 64 | PF00244 | 0.487 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.703 |
LIG_BIR_III_4 | 84 | 88 | PF00653 | 0.497 |
LIG_CaM_IQ_9 | 197 | 212 | PF13499 | 0.419 |
LIG_FHA_1 | 188 | 194 | PF00498 | 0.429 |
LIG_FHA_1 | 27 | 33 | PF00498 | 0.541 |
LIG_LIR_Apic_2 | 129 | 134 | PF02991 | 0.505 |
LIG_LIR_Apic_2 | 34 | 40 | PF02991 | 0.539 |
LIG_LIR_Gen_1 | 42 | 48 | PF02991 | 0.483 |
LIG_LIR_Gen_1 | 58 | 66 | PF02991 | 0.512 |
LIG_LIR_Gen_1 | 75 | 86 | PF02991 | 0.474 |
LIG_LIR_Nem_3 | 42 | 47 | PF02991 | 0.484 |
LIG_LIR_Nem_3 | 58 | 64 | PF02991 | 0.506 |
LIG_PCNA_yPIPBox_3 | 124 | 136 | PF02747 | 0.548 |
LIG_Pex14_2 | 112 | 116 | PF04695 | 0.478 |
LIG_SH2_CRK | 13 | 17 | PF00017 | 0.454 |
LIG_SH2_CRK | 88 | 92 | PF00017 | 0.525 |
LIG_SH2_STAT5 | 234 | 237 | PF00017 | 0.352 |
LIG_SH3_3 | 114 | 120 | PF00018 | 0.595 |
LIG_SH3_3 | 27 | 33 | PF00018 | 0.548 |
LIG_TRAF2_1 | 70 | 73 | PF00917 | 0.650 |
LIG_WRC_WIRS_1 | 234 | 239 | PF05994 | 0.398 |
MOD_CK1_1 | 49 | 55 | PF00069 | 0.399 |
MOD_GlcNHglycan | 143 | 146 | PF01048 | 0.473 |
MOD_GlcNHglycan | 149 | 152 | PF01048 | 0.540 |
MOD_GlcNHglycan | 253 | 256 | PF01048 | 0.647 |
MOD_GlcNHglycan | 51 | 54 | PF01048 | 0.438 |
MOD_GlcNHglycan | 58 | 61 | PF01048 | 0.430 |
MOD_GSK3_1 | 246 | 253 | PF00069 | 0.671 |
MOD_GSK3_1 | 31 | 38 | PF00069 | 0.446 |
MOD_N-GLC_1 | 62 | 67 | PF02516 | 0.440 |
MOD_NEK2_1 | 140 | 145 | PF00069 | 0.520 |
MOD_NEK2_1 | 200 | 205 | PF00069 | 0.262 |
MOD_NEK2_1 | 211 | 216 | PF00069 | 0.296 |
MOD_NEK2_1 | 56 | 61 | PF00069 | 0.358 |
MOD_NEK2_2 | 212 | 217 | PF00069 | 0.293 |
MOD_PIKK_1 | 246 | 252 | PF00454 | 0.608 |
MOD_PKA_2 | 201 | 207 | PF00069 | 0.296 |
MOD_PKA_2 | 49 | 55 | PF00069 | 0.384 |
MOD_PKA_2 | 56 | 62 | PF00069 | 0.333 |
MOD_Plk_1 | 72 | 78 | PF00069 | 0.485 |
MOD_ProDKin_1 | 26 | 32 | PF00069 | 0.495 |
MOD_SUMO_for_1 | 70 | 73 | PF00179 | 0.450 |
MOD_SUMO_rev_2 | 150 | 156 | PF00179 | 0.273 |
MOD_SUMO_rev_2 | 163 | 168 | PF00179 | 0.417 |
TRG_DiLeu_BaEn_4 | 7 | 13 | PF01217 | 0.493 |
TRG_ENDOCYTIC_2 | 13 | 16 | PF00928 | 0.310 |
TRG_ENDOCYTIC_2 | 234 | 237 | PF00928 | 0.352 |
TRG_ENDOCYTIC_2 | 78 | 81 | PF00928 | 0.336 |
TRG_ENDOCYTIC_2 | 88 | 91 | PF00928 | 0.325 |
TRG_NES_CRM1_1 | 106 | 118 | PF08389 | 0.482 |
TRG_Pf-PMV_PEXEL_1 | 205 | 210 | PF00026 | 0.258 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P366 | Leptomonas seymouri | 79% | 97% |
A0A0S4JL59 | Bodo saltans | 45% | 100% |
A0A1X0NYJ8 | Trypanosomatidae | 57% | 100% |
A0A3Q8IE03 | Leishmania donovani | 100% | 100% |
A0A422NSS3 | Trypanosoma rangeli | 58% | 100% |
A4HBY4 | Leishmania braziliensis | 89% | 100% |
D0A159 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 53% | 100% |
E9AVB3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
Q4QC67 | Leishmania major | 96% | 100% |
V5BHA3 | Trypanosoma cruzi | 57% | 100% |